Other than finding the right blood tissue type match, nothing is more important than the volume of viable stem cells at transplant. And no other organization delivers more viable stem cells than StemCyte Family and StemCyte because of our Stem Cell Optimization Process.

This process gives families the best opportunity should their baby or a family member ever need the life-saving miracle of cord blood.

StemCyte’s high transplant engraftment rate is the result of our proprietary, modified whole blood processing (five patents pending). It consistently delivers an unexcelled post-processing cell yield and post-thaw cell recovery. These higher viable stem cell dosages are critical to a positive transplant outcome.

Collection: StemCyte s Stem Cell Optimization Process begins with a collection process strongly preferred by transplant physicians. We only use blood bags for collection. Blood bags represent a superior closed system that minimizes the risk of bacterial and fungal contamination, and they are strongly preferred by transplant physicians for their safety.

Transport:  Our validated, temperature-controlled cord blood collection shipping container meets the same higher standards recommended by the FDA in their draft cord blood guidance for unrelated cord blood shipping in order to maintain the optimal temperature for transportation of your baby's unique cells. This protects your family's precious stem cells during shipping to our laboratory through all 4 seasons and weather extremes.

Processing: With our processing method, over 99% of the nucleated cells received at collection are successfully recovered. This recovery rate significantly exceeds other volume reduction methods, which published data shows yield anywhere between 25%-80%.

Freezing and Thawing: Our unprecedented post-thaw cell viability in the range of 90% is due to two specific aspects of the process: 1) the highly efficient procedure and the meticulous care taken in adding the cryogenic freezing agent (DMSO), which can kill cells with overexposure; and 2) the validated and unique 'cold-thawing' procedure that minimizes stem cell loss resulting from post-thaw.

Testing: All cord blood units are tested for sterility and screened for all the blood bank virus diseases markers, by both serological and nucleic acid tests (NAT) using both maternal and cord blood samples.

Higher Standards: Over 400 standard operating procedures and quality controls monitor the cord blood banking process, and five patents have been filed surrounding StemCyte s proprietary stem cell laboratory processing methods.